PMC:7243778 / 744-897 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T5","span":{"begin":52,"end":56},"obj":"Body_part"},{"id":"T6","span":{"begin":84,"end":88},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma25056"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma256135"}],"text":"ies is expected to activate when the pathogens come back. Exploiting this nature of body protection, neutralizing antibodies have been investigated. Lear"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T11","span":{"begin":19,"end":27},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"ies is expected to activate when the pathogens come back. Exploiting this nature of body protection, neutralizing antibodies have been investigated. Lear"}

{"project":"LitCovid-sentences","denotations":[{"id":"T10","span":{"begin":58,"end":148},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ies is expected to activate when the pathogens come back. Exploiting this nature of body protection, neutralizing antibodies have been investigated. Lear"}